{"id":"W4295679167","doi":"10.1007/s00280-022-04471-x","title":"Population pharmacokinetics of zanidatamab, an anti-HER2 biparatopic antibody, in patients with advanced or metastatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Dosing; Pharmacokinetics; Medicine; Population; Body surface area; Cancer; Internal medicine; Pharmacology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006204803,0.0003066644,0.0009031111,0.0002207766,0.0001908204,0.0006917155,0.0001914149,0.0004088152,0.000932548],"category_scores_gemma":[0.001972247,0.0003701139,0.0004511238,0.0002899175,0.0002242187,0.0006796437,0.0002327998,0.001252349,0.0001988342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000564615,"about_ca_system_score_gemma":0.0005033008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001060031,"about_ca_topic_score_gemma":0.00130317,"domain_scores_codex":[0.9995902,0.0001518753,0.00002068768,0.00009750704,0.00007707779,0.00006257697],"domain_scores_gemma":[0.9995883,0.0001307903,0.0001126973,0.00005204562,0.0000337485,0.00008241402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1789464,0.002750081,0.577362,0.000230643,0.003986193,0.0007055852,0.0008650197,0.01088436,0.06167889,0.0009229794,0.004190916,0.1574769],"study_design_scores_gemma":[0.00466957,0.02944537,0.9368834,0.00002643511,0.001623983,0.001510123,0.0002782188,0.01213579,0.005577807,0.0008566604,0.006900783,0.00009183103],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970002,0.0009852501,0.0007184296,0.000123161,0.0000156812,0.00002911025,0.0002420605,0.00005265237,0.000833513],"genre_scores_gemma":[0.9983457,0.0003435867,0.0003180012,0.0001206253,0.00002608558,0.00002567648,0.0003818107,0.00001883195,0.0004196479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001060031,"threshold_uncertainty_score":0.004096627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03515167065945417,"score_gpt":0.4309133207851407,"score_spread":0.3957616501256865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}